Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut Microbiome and Organ Fibrosis
Carolina F. F. A. Costa, Benedita Sampaio‐Maia, Ricardo Araújo, et al.
Nutrients (2022) Vol. 14, Iss. 2, pp. 352-352
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

The differential crosstalk of the skin–gut microbiome axis as a new emerging actor in systemic sclerosis
Edda Russo, Silvia Bellando-Randone, Davide Carboni, et al.
Lara D. Veeken (2023) Vol. 63, Iss. 1, pp. 226-234
Closed Access | Times Cited: 15
The Gut-Peritoneum Axis in Peritoneal Dialysis and Peritoneal Fibrosis
N. Stepanova
Kidney Medicine (2023) Vol. 5, Iss. 6, pp. 100645-100645
Open Access | Times Cited: 13
Macrophages in organ fibrosis: from pathogenesis to therapeutic targets
Yuanyuan Jiang, Rong Cai, Yu Huang, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 5
The Novel Effect and Potential Mechanism of Lactoferrin on Organ Fibrosis Prevention
Yonghui Yu, Juan Fang, Yingying Li, et al.
Nutrients (2025) Vol. 17, Iss. 1, pp. 197-197
Open Access
Murine gut microbiota dysbiosis via enteric infection modulates the foreign body response to a distal biomaterial implant
Brenda Yang, Natalie Rutkowski, Anna Ruta, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Modulatory effects of traditional Chinese medicines on gut microbiota and the microbiota-gut-x axis
Tingting Luo, Qingya Che, Ziyi Guo, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Liver fibrosis as a barometer of systemic health by gauging the risk of extrahepatic disease
Amedeo Lonardo, Stefano Ballestri, György Baffy, et al.
Metabolism and Target Organ Damage (2024) Vol. 4, Iss. 4
Open Access | Times Cited: 4
Alterations of the gut microbiota in patients with diabetic nephropathy and its association with the renin-angiotensin system
Fatemeh Zali, Abdorrahim Absalan, Golnaz Bahramali, et al.
Journal of Diabetes & Metabolic Disorders (2025) Vol. 24, Iss. 1
Closed Access
Cardiometabolic disease risk in gorillas is associated with altered gut microbial metabolism
Samuel Davison, Anna Mascellani, Zoë Ward, et al.
npj Biofilms and Microbiomes (2025) Vol. 11, Iss. 1
Open Access
Scutellarin Alleviates CCl4-Induced Liver Fibrosis by Regulating Intestinal Flora and PI3K/AKT Signaling Axis
Xin Li, Wanqi Yang, Y Weng, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 2997-2997
Open Access
Gut commensal bacterium Bacteroides vulgatus exacerbates helminth-induced cardiac fibrosis through succinate accumulation
Jiaqi Wang, Jiali Yin, Xiaolei Liu, et al.
PLoS Pathogens (2025) Vol. 21, Iss. 4, pp. e1013069-e1013069
Open Access
Targeting Gut Microbiota as a Novel Strategy for Prevention and Treatment of Hypertension, Atrial Fibrillation and Heart Failure: Current Knowledge and Future Perspectives
Oxana M. Drapkina, A. A. Yafarova, A. N. Kaburova, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 2019-2019
Open Access | Times Cited: 18
Recent advances of gut microbiota in chronic kidney disease patients
Ying‐Yong Zhao
Exploration of Medicine (2022), pp. 260-274
Open Access | Times Cited: 17
The Role of Genetic and Epigenetic Regulation in Intestinal Fibrosis in Inflammatory Bowel Disease: A Descending Process or a Programmed Consequence?
Sara Jarmakiewicz-Czaja, Aneta Sokal, Katarzyna Ferenc, et al.
Genes (2023) Vol. 14, Iss. 6, pp. 1167-1167
Open Access | Times Cited: 10
Role of Nonalcoholic Fatty Liver Disease in Periodontitis: A Bidirectional Relationship
Hardika S Vegda, Bhavin Patel, Gaurav Girdhar, et al.
Cureus (2024)
Open Access | Times Cited: 3
Natural polysaccharides as potential anti-fibrotic agents: A review of their progress
Ming Wang, Simin Lu, Hui Zhao, et al.
Life Sciences (2022) Vol. 308, pp. 120953-120953
Closed Access | Times Cited: 13
Zamzam Water Mitigates Cardiac Toxicity Risk through Modulation of GUT Microbiota and the Renin-angiotensin System
Ryan A. Sheikh, Mr. Nawazish Ali Nadeem, Turky Omar Asar, et al.
Current Pharmaceutical Design (2024) Vol. 30, Iss. 14, pp. 1115-1127
Closed Access | Times Cited: 2
Elucidating the Molecular Pathways and Therapeutic Interventions of Gaseous Mediators in the Context of Fibrosis
Aohan Li, Siyuan Wu, Qian Li, et al.
Antioxidants (2024) Vol. 13, Iss. 5, pp. 515-515
Open Access | Times Cited: 2
Gut microbiome and metabolomics in systemic sclerosis: feature, link and mechanisms
Qicen Yao, Wenfeng Tan, Feihu Bai
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Qige Huxin Formula Attenuates Isoprenaline-Induced Cardiac Fibrosis in Mice via Modulating Gut Microbiota and Protecting Intestinal Integrity
Lipeng Shi, Xuqin Du, Biao Zuo, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-11
Open Access | Times Cited: 12
Clostridium butyricum and Bifidobacterium pseudolongum Attenuate the Development of Cardiac Fibrosis in Mice
Jiaqi Wang, Jiahuan Chen, Linquan Li, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 6
Open Access | Times Cited: 11
Akkermansia muciniphila participates in the host protection against helminth-induced cardiac fibrosis via TLR2
Jiaqi Wang, Xiaolei Liu, Ruohang Sun, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 10, pp. e1011683-e1011683
Open Access | Times Cited: 6
Multi‐omic network analysis identified betacellulin as a novel target of omega‐3 fatty acid attenuation of western diet‐induced nonalcoholic steatohepatitis
Jyothi Padiadpu, Manuel García‐Jaramillo, Nolan K. Newman, et al.
EMBO Molecular Medicine (2023) Vol. 15, Iss. 11
Open Access | Times Cited: 6
Oral Pathogenic Bacteria and the Oral–Gut–Liver Axis: A New Understanding of Chronic Liver Diseases
Yumeng Lei, Simin Li, Mingxin He, et al.
Diagnostics (2023) Vol. 13, Iss. 21, pp. 3324-3324
Open Access | Times Cited: 6
Evaluation of the contribution of gut microbiome dysbiosis to cardiac surgery-associated acute kidney injury by comparative metagenome analysis
Ying Li, Xinyi Jiang, Jingchun Chen, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top